Matsui, Kazuaki
Kawakubo, Hirofumi http://orcid.org/0000-0002-6246-7023
Matsuda, Satoru
Hirata, Yuki
Irino, Tomoyuki
Fukuda, Kazumasa
Nakamura, Rieko
Okita, Hajime
Kitagawa, Yuko
Funding for this research was provided by:
Taiho Pharmaceutical
Chugai Pharmaceutical
Yakult Honsha
Daiichi-Sankyo
Merck Serono Co., Ltd.
Asahi Kasei Co., Ltd.
EA Pharma Co., Ltd.
Otsuka Pharmaceutical
Takeda Pharmaceutical Company
Otsuka Pharmaceutical Factory Inc.
Shionogi
Kaken Pharmaceutical Co., Ltd.
Kowa Pharmaceutical Co., Ltd.
Astellas Pharma
Medicon Inc.
Dainippon Sumitomo Pharma
Taisho Toyama Pharmaceutical Company
Kyowa Hakko Kirin
Pfizer Japan Inc.
Ono Pharmaceutical
Nihon Pharmaceutical Co., Ltd.
Japan Blood Products Organization
Medtronic Japan Co., Ltd.
Sanofi K.K.
Eisai
Tsumura and Company
KCI Licensing Inc.
Abbott Japan
Fujifilm Toyama Chemical Co., Ltd.
Article History
Received: 20 January 2022
Accepted: 10 May 2023
First Online: 24 May 2023
Declarations
:
: All procedures were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1964 and later versions.
: Yuko Kitagawa received grants from Taiho Pharmaceutical Co., Ltd.; Chugai Pharmaceutical Co., Ltd.; Yakult Honsha Co., Ltd.; Daiichi Sankyo; Merck Serono Co., Ltd.; Asahi Kasei Co., Ltd.; EA Pharma Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.; Takeda Pharmaceutical Co., Ltd.; Otsuka Pharmaceutical Factory Inc.; Shionogi & Co., Ltd.; Kaken Pharmaceutical Co., Ltd.; Kowa Pharmaceutical Co., Ltd.; Astellas Pharma Inc.; Medicon Inc.; Dainippon Sumitomo Pharma Co., Ltd.; Taisho Toyama Pharmaceutical Co., Ltd.; Kyowa Hakko Kirin Co., Ltd.; Pfizer Japan Inc.; Ono Pharmaceutical Co., Ltd.; Nihon Pharmaceutical Co., Ltd.; Japan Blood Products Organization; Medtronic Japan Co., Ltd.; Sanofi K.K.; Eisai Co., Ltd.; Tsumura & Co.; KCI Licensing Inc.; Abbott Japan Co., Ltd.; and Fujifilm Toyama Chemical Co., Ltd. outside the submitted work. Kazuaki Matsui, Hirofumi Kawakubo, Satoru Matsuda, Yuki Hirata, Tomoyuki Irino, Kazumasa Fukuda, Rieko Nakamura, and Hajime Okita declare no conflicts of interest.